First dose target attainment with extended infusion regimens of piperacillin and meropenem

被引：0
|
作者：
Gustaf Beijer [1 ]
Maria Swartling [4 ]
Elisabet I. Nielsen [7 ]
Olof Breuer [7 ]
Christian G. Giske [1 ]
Erik Eliasson [4 ]
Johan Petersson [3 ]
机构：
[1] Karolinska University Hospital,MDK, Medical Unit of Clinical Pharmacology
[2] Karolinska University Hospital,Function Perioperative Medicine and Intensive Care
[3] Karolinska University Hospital,MDK, Medical Unit of Clinical Microbiology
[4] Karolinska Institutet,Division of Clinical Pharmacology, Department of Laboratory Medicine
[5] Karolinska Institutet,Section of Anaesthesiology & Intensive Care Medicine, Department of Physiology and Pharmacology
[6] Karolinska Institutet,Division of Clinical Microbiology, Department of Laboratory Medicine
[7] Uppsala University,Department of Pharmacy
来源：
Critical Care | / 29卷 / 1期
关键词：
Beta-lactam antibiotics; Intensive care; Therapeutic drug monitoring; Pharmacokinetics; Pharmacodynamics;
D O I：
10.1186/s13054-025-05445-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
    Dhaese, Sofie A. M.
    Thooft, Alexander D. J.
    Farkas, Andras
    Lipman, Jeffrey
    Verstraete, Alain G.
    Stove, Veronique
    Roberts, Jason A.
    De Waele, Jan J.
    JOURNAL OF CRITICAL CARE, 2019, 52 : 75 - 79
  • [2] Extended versus bolus infusion of meropenem and piperacillin: a pharmacolcinetic analysis
    De Waele, J.
    Carlier, M.
    Hoste, E.
    Depuydt, P.
    Decruyenaere, J.
    Wallis, S. C.
    Lipman, J.
    Roberts, J. A.
    MINERVA ANESTESIOLOGICA, 2014, 80 (12) : 1302 - 1309
  • [3] Therapeutic Target Attainment of 3-Hour Extended Infusion of Meropenem in Patients With Septic Burns
    Messiano, Claudia Garcia
    Morales Junior, Ronaldo
    Pereira, Gabriela Otofuji
    da Silva Junior, Elson Mendes
    Gomez, David de Souza
    Cavani Jorge Santos, Silvia Regina
    CLINICAL THERAPEUTICS, 2022, 44 (04) : 624 - 629
  • [4] Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    Carlier, Mieke
    Carrette, Sofie
    Roberts, Jason A.
    Stove, Veronique
    Verstraete, Alain
    Hoste, Eric
    Depuydt, Pieter
    Decruyenaere, Johan
    Lipman, Jeffrey
    Wallis, Steven C.
    De Waele, Jan J.
    CRITICAL CARE, 2013, 17 (03):
  • [5] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion
    Tournayre, Sarah
    Mathieu, Olivier
    Villiet, Maxime
    Besnard, Noemie
    Brunot, Vincent
    Daubin, Delphine
    Platon, Laura
    Corne, Philippe
    Klouche, Kada
    Larcher, Romaric
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
  • [6] Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study
    Frippiat, Frederic
    Musuamba, Flora Tshinanu
    Seidel, Laurence
    Albert, Adelin
    Denooz, Raphael
    Charlier, Corinne
    Van Bambeke, Francoise
    Wallemacq, Pierre
    Descy, Julie
    Lambermont, Bernard
    Layios, Nathalie
    Damas, Pierre
    Moutschen, Michel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) : 207 - 216
  • [7] Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
    Mieke Carlier
    Sofie Carrette
    Jason A Roberts
    Veronique Stove
    Alain Verstraete
    Eric Hoste
    Pieter Depuydt
    Johan Decruyenaere
    Jeffrey Lipman
    Steven C Wallis
    Jan J De Waele
    Critical Care, 17
  • [8] Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020
    Drager, Sarah
    von Rotz, Matthias
    Labhardt, Niklaus D.
    Siegemund, Martin
    Rentsch, Katharina M.
    Osthoff, Michael
    Franzeck, Fabian C.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [9] Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
    De Corte, Thomas
    Verhaeghe, Jarne
    Dhaese, Sofie
    Van Vooren, Sarah
    Boelens, Jerina
    G. Verstraete, Alain
    Stove, Veronique
    Ongenae, Femke
    De Bus, Liesbet
    Depuydt, Pieter
    Van Hoecke, Sofie
    J. De Waele, Jan
    ANNALS OF INTENSIVE CARE, 2023, 13 (01)
  • [10] Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
    Thomas De Corte
    Jarne Verhaeghe
    Sofie Dhaese
    Sarah Van Vooren
    Jerina Boelens
    Alain G. Verstraete
    Veronique Stove
    Femke Ongenae
    Liesbet De Bus
    Pieter Depuydt
    Sofie Van Hoecke
    Jan J. De Waele
    Annals of Intensive Care, 13
12345